The siRNA suppressed BNCT-induced PD-L1 upregulation, simultaneously activated T-cell immunity, inhibited DNA repair mechanisms, and generated potent anti-tumor immune responses against distal/metastatic lesions [138]. Here, CD274 is linked to neoplasm.